Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lessons in Affect Regulation to Keep Stress and Pain UndeR Control (LARKSPUR R34) (LARKSPUR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03699553
Recruitment Status : Recruiting
First Posted : October 9, 2018
Last Update Posted : September 10, 2020
Sponsor:
Collaborator:
BraveNet
Information provided by (Responsible Party):
Judith Moskowitz, Northwestern University

Brief Summary:
Chronic pain affects millions of Americans but integrative as well as conventional treatments fall short in terms of alleviating this pain. The investigators are testing a tailored online positive affect skills intervention through a high-quality, randomized controlled trial for people with chronic musculoskeletal pain. The proposed work holds promise as an effective, low cost, easily disseminated intervention to help people cope with chronic pain, decrease depression and distress that pose barriers to optimal adherence, and potentially boost the efficacy of integrative as well as conventional pain treatments.

Condition or disease Intervention/treatment Phase
Chronic Pain Musculoskeletal Pain Behavioral: LARKSPUR; Online Positive Emotions Skills for Individuals with Chronic Musculoskeletal Pain Behavioral: Emotion Reporting Control Group Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: 40 participants will be randomized to the LARKSPUR Study. 20 will receive the online intervention and 20 will report their daily emotions for the same duration as the intervention. The 20 individuals assigned to the emotion reporting (control group) arm will receive the online intervention after completing the final assessment, 12 weeks after baseline.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Positive Affect Regulation as Adjuvant to Integrative Therapies for Chronic Pain: Development of the LARKSPUR Clinic-Based Intervention
Actual Study Start Date : October 15, 2018
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Chronic Pain

Arm Intervention/treatment
Experimental: Intervention
Participants will receive the online LARKSPUR intervention which lasts about 5-6 weeks, receiving the positive emotions skills through the website, and logging on to the website for about 5-10 minutes each day for that period. Assessments will be taken at baseline, post-intervention (8 weeks after the baseline), and 12 weeks after baseline (1 month post intervention).
Behavioral: LARKSPUR; Online Positive Emotions Skills for Individuals with Chronic Musculoskeletal Pain
8 positive emotion skills taught over 5-6 weeks to help individuals cope with chronic pain and stress.

Active Comparator: Emotion Reporting Control
Participants will report their emotions for 5-6 weeks by logging on to the website for about 5 minutes each day. Assessments will be taken at baseline, 8 weeks after baseline, and 12 weeks after baseline. After 12 weeks, participants will receive access to the LARKSPUR intervention online.
Behavioral: Emotion Reporting Control Group
Attention matched control condition, participants will report their daily emotions over 5-6 weeks online.




Primary Outcome Measures :
  1. Retention to the LARKSPUR Study from baseline to 8 weeks post baseline [ Time Frame: 8 weeks; from baseline to 8 weeks post baseline ]
    Retention will be defined as responding to the assessments at baseline and at 8 weeks post baseline

  2. Retention to the LARKSPUR Study from baseline to 12 weeks post baseline [ Time Frame: 12 weeks; from baseline to 12 weeks post baseline ]
    Retention will be defined as responding to the assessments at baseline and at 12 weeks post baseline


Secondary Outcome Measures :
  1. Self-Reported Medication use at baseline [ Time Frame: Administered at baseline ]
    Measuring medication use by asking: "Have you used any prescription or non-prescription medication for your pain in the last 7 days?" with a Yes-No response. If "Yes" is selected, options include 13 types of medications as response options, with 2 follow-up question for each medication selected: "How many milligrams (mg) per pill, if you know it?" and "What is the average number of pills per day?"

  2. Self-Reported Medication use at 8 weeks post baseline [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring medication use by asking: "Have you used any prescription or non-prescription medication for your pain in the last 7 days?" with a Yes-No response. If "Yes" is selected, options include 13 types of medications as response options, with 2 follow-up question for each medication selected: "How many milligrams (mg) per pill, if you know it?" and "What is the average number of pills per day?"

  3. Self-Reported Medication use at 12 weeks post baseline [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring medication use by asking: "Have you used any prescription or non-prescription medication for your pain in the last 7 days?" with a Yes-No response. If "Yes" is selected, options include 13 types of medications as response options, with 2 follow-up question for each medication selected: "How many milligrams (mg) per pill, if you know it?" and "What is the average number of pills per day?"

  4. Modified Differential Emotions Scale (mDES) [ Time Frame: Administered daily for 5 weeks of the intervention period ]
    Measuring positive and negative affect through a 26-item modified version of the Differential Emotions Scale with the anchor: "How much have you felt each of these emotions over the PAST DAY?" with items including "amused or fun-loving" "angry, irritated, or frustrated" and "anxious or scared." Response scale is from 1 Not at all to 9 All the time.

  5. Daily Inventory of Stressful Events (DISE) [ Time Frame: Administered daily for 5 weeks of the intervention period ]
    Measuring stress through a 7-item scale with the following anchor: "Over the PAST DAY, have you…" and the items include: "Had an argument or disagreement with someone?" and "Almost had an argument or disagreement but decided to let it pass to avoid disagreement?" The response scale is from 0 Didn't happen to 4 Very Stressful.

  6. Pain Level, measured by a single-item pain question [ Time Frame: Administered daily for 5 weeks of the intervention period ]
    Measuring daily pain level through the single-item: "What is your level of pain right now?" Response items range from 0 No Pain to 10 Pain as bad as you can imagine.

  7. Positive Affect using the NIH Toolbox for Positive Affect, Short-Form (Baseline) [ Time Frame: Administered at baseline ]
    A 16-item measure that asks: "In the past 7 days…" and there are 15 items such as "I felt cheerful" "I felt attentive" "I felt delighted" "I felt happy." The response scale ranges from 1 Not at all to 5 Very much.

  8. Positive Affect using the NIH Toolbox for Positive Affect, Short-Form (8 weeks post baseline) [ Time Frame: Administered at 8 weeks post baseline ]
    A 16-item measure that asks: "In the past 7 days…" and there are 15 items such as "I felt cheerful" "I felt attentive" "I felt delighted" "I felt happy." The response scale ranges from 1 Not at all to 5 Very much.

  9. Positive Affect using the NIH Toolbox for Positive Affect, Short-Form (12 weeks post baseline) [ Time Frame: Administered at 12 weeks post baseline ]
    A 16-item measure that asks: "In the past 7 days…" and there are 15 items such as "I felt cheerful" "I felt attentive" "I felt delighted" "I felt happy." The response scale ranges from 1 Not at all to 5 Very much.

  10. Emotional Support at baseline using the NIH Toolbox for Emotional Support [ Time Frame: Administered at baseline ]
    Measuring emotional support through the 4-item NIH Toolbox measure for emotional support (4a) with questions such as "I have someone who will listen to me when I need to talk" and "I have someone to confide in or talk about myself or my problems." The response is on a 5-point scale from Never to Always.

  11. Emotional Support at 8 weeks post baseline using the NIH Toolbox for Emotional Support [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring emotional support through the 4-item NIH Toolbox measure for emotional support (4a) with questions such as "I have someone who will listen to me when I need to talk" and "I have someone to confide in or talk about myself or my problems." The response is on a 5-point scale from Never to Always.

  12. Emotional Support at 12 weeks post baseline using the NIH Toolbox for Emotional Support [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring emotional support through the 4-item NIH Toolbox measure for emotional support (4a) with questions such as "I have someone who will listen to me when I need to talk" and "I have someone to confide in or talk about myself or my problems." The response is on a 5-point scale from Never to Always.

  13. Physical Function at Baseline through the PROMIS measure for physical function [ Time Frame: Administered at baseline ]
    Measuring physical function through the 4-item PROMIS Short-From v2.0 - Physical Function 4a. Questions include: "Are you able to do chores such as vacuuming or yard work?" or "Are you able to go up and down stairs at a normal pace?" Responses are on a 5-point scale from "Without any difficulty" to "Unable to do."

  14. Physical Function at 8 weeks post baseline through the PROMIS measure for physical function [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring physical function through the 4-item PROMIS Short-From v2.0 - Physical Function 4a. Questions include: "Are you able to do chores such as vacuuming or yard work?" or "Are you able to go up and down stairs at a normal pace?" Responses are on a 5-point scale from "Without any difficulty" to "Unable to do."

  15. Physical Function at 12 weeks post baseline through the PROMIS measure for physical function [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring physical function through the 4-item PROMIS Short-From v2.0 - Physical Function 4a. Questions include: "Are you able to do chores such as vacuuming or yard work?" or "Are you able to go up and down stairs at a normal pace?" Responses are on a 5-point scale from "Without any difficulty" to "Unable to do."

  16. Pain on average over 7 days at baseline through a single-item question [ Time Frame: Administered at baseline ]
    Measuring pain on average over the past 7 days with a single-item question: "In the past 7 days, how would you rate your pain on average?" The response scale ranges from 0 No pain to 10 Pain as bad as you can imagine.

  17. Pain on average over 7 days at 8 weeks post baseline through a single-item question [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring pain on average over the past 7 days with a single-item question: "In the past 7 days, how would you rate your pain on average?" The response scale ranges from 0 No pain to 10 Pain as bad as you can imagine.

  18. Pain on average over 7 days at 12 weeks post baseline through a single-item question [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring pain on average over the past 7 days with a single-item question: "In the past 7 days, how would you rate your pain on average?" The response scale ranges from 0 No pain to 10 Pain as bad as you can imagine.

  19. Depression at baseline using the PROMIS measure [ Time Frame: Administered at baseline ]
    Measuring depression using the PROMIS Short-Form v1.0-Depression 4a with 4 items including: "In the past 7 days I felt worthless" and "In the past 7 days I felt helpless." The 5-point response scale ranges from Never to Always.

  20. Depression at 8 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring depression using the PROMIS Short-Form v1.0-Depression 4a with 4 items including: "In the past 7 days I felt worthless" and "In the past 7 days I felt helpless." The 5-point response scale ranges from Never to Always.

  21. Depression at 12 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring depression using the PROMIS Short-Form v1.0-Depression 4a with 4 items including: "In the past 7 days I felt worthless" and "In the past 7 days I felt helpless." The 5-point response scale ranges from Never to Always.

  22. Anxiety at baseline using the PROMIS measure [ Time Frame: Administered at baseline ]
    Measuring anxiety using the PROMIS Short-Form v1.0-Anxiety 4a with 4 items such as "In the past 7 days I felt fearful" and "In the past 7 days I found it hard to focus on anything other than my anxiety." The 5-point response scale ranges from Never to Always.

  23. Anxiety at 8 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring anxiety using the PROMIS Short-Form v1.0-Anxiety 4a with 4 items such as "In the past 7 days I felt fearful" and "In the past 7 days I found it hard to focus on anything other than my anxiety." The 5-point response scale ranges from Never to Always.

  24. Anxiety at 12 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring anxiety using the PROMIS Short-Form v1.0-Anxiety 4a with 4 items such as "In the past 7 days I felt fearful" and "In the past 7 days I found it hard to focus on anything other than my anxiety." The 5-point response scale ranges from Never to Always.

  25. Pain Intensity at baseline using the PROMIS measure [ Time Frame: Administered at baseline ]
    Measuring pain intensity using the PROMIS Scale v.1.0- Pain Intensity 3a which consists of 3 questions with the anchor: "In the past 7 days…" and the items include "How intense was your pain at its worst?" "How intense was your average pain?" and "What is your level of pain right now?" The 5-item response scale ranges from "Had no pain" to "Very severe."

  26. Pain Intensity at 8 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring pain intensity using the PROMIS Scale v.1.0- Pain Intensity 3a which consists of 3 questions with the anchor: "In the past 7 days…" and the items include "How intense was your pain at its worst?" "How intense was your average pain?" and "What is your level of pain right now?" The 5-item response scale ranges from "Had no pain" to "Very severe."

  27. Pain Intensity at 12 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring pain intensity using the PROMIS Scale v.1.0- Pain Intensity 3a which consists of 3 questions with the anchor: "In the past 7 days…" and the items include "How intense was your pain at its worst?" "How intense was your average pain?" and "What is your level of pain right now?" The 5-item response scale ranges from "Had no pain" to "Very severe."

  28. Pain interference at baseline using the PROMIS measure [ Time Frame: Administered at baseline ]
    Measuring pain interference using the PROMIS SF v1.0 - pain Interference 8a with the anchor: "In the past 7 days…" with 8 items including: "How much did pain interfere with your day to day activities?" "How much did pain interfere with work around the home?" or "How much did pain interfere with your ability to participate in social activities?" The 5-item response scale ranges from "Not at all" to "Very much."

  29. Pain interference at 8 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring pain interference using the PROMIS SF v1.0 - pain Interference 8a with the anchor: "In the past 7 days…" with 8 items including: "How much did pain interfere with your day to day activities?" "How much did pain interfere with work around the home?" or "How much did pain interfere with your ability to participate in social activities?" The 5-item response scale ranges from "Not at all" to "Very much."

  30. Pain interference at 12 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring pain interference using the PROMIS SF v1.0 - pain Interference 8a with the anchor: "In the past 7 days…" with 8 items including: "How much did pain interfere with your day to day activities?" "How much did pain interfere with work around the home?" or "How much did pain interfere with your ability to participate in social activities?" The 5-item response scale ranges from "Not at all" to "Very much."

  31. Pain Self Efficacy at baseline (PSEQ) [ Time Frame: Administered at baseline ]
    Measuring pain self efficacy using the Pain Self Efficacy Questionnaire (PSEQ) which has 10 items with the anchor: "Please rate how confident you are that you can do the following things at present, despite the pain." Items include: "I can enjoy things, despite the pain." "I can cope with my pain in most situations." "I can cope with my pain without medication." The response scale ranges from 0 Not at all Confident to 6 Completely Confident.

  32. Pain Self Efficacy at 8 weeks post baseline (PSEQ) [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring pain self efficacy using the Pain Self Efficacy Questionnaire (PSEQ) which has 10 items with the anchor: "Please rate how confident you are that you can do the following things at present, despite the pain." Items include: "I can enjoy things, despite the pain." "I can cope with my pain in most situations." "I can cope with my pain without medication." The response scale ranges from 0 Not at all Confident to 6 Completely Confident.

  33. Pain Self Efficacy at 12 weeks post baseline (PSEQ) [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring pain self efficacy using the Pain Self Efficacy Questionnaire (PSEQ) which has 10 items with the anchor: "Please rate how confident you are that you can do the following things at present, despite the pain." Items include: "I can enjoy things, despite the pain." "I can cope with my pain in most situations." "I can cope with my pain without medication." The response scale ranges from 0 Not at all Confident to 6 Completely Confident.

  34. Pain resilience at baseline [ Time Frame: Administered at baseline ]
    Measuring pain resilience using the 14 item Pain Resilience Scale. The anchor is: "When faced with intense or prolonged pain…" Items include "I get back out there" "I push through it" "I keep a positive attitude" and "I try to stay relaxed." The 5-item response scale ranges from "0 Not at all" to "4 All the time."

  35. Pain resilience at 8 weeks post baseline [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring pain resilience using the 14 item Pain Resilience Scale. The anchor is: "When faced with intense or prolonged pain…" Items include "I get back out there" "I push through it" "I keep a positive attitude" and "I try to stay relaxed." The 5-item response scale ranges from "0 Not at all" to "4 All the time."

  36. Pain resilience at 12 weeks post baseline [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring pain resilience using the 14 item Pain Resilience Scale. The anchor is: "When faced with intense or prolonged pain…" Items include "I get back out there" "I push through it" "I keep a positive attitude" and "I try to stay relaxed." The 5-item response scale ranges from "0 Not at all" to "4 All the time."

  37. Pain catastrophizing at baseline [ Time Frame: Administered at baseline ]
    Measuring pain catastrophizing using the Pain Catastrophizing Scale which has 13 items with the anchor: "When I'm in pain…" Items include: "I feel I can't go on." "I feel I can't stand it anymore." "I keep thinking about how much it hurts." The response scale ranges from 0 Not al all to 4 All the Time.

  38. Pain catastrophizing at 8 weeks post baseline [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring pain catastrophizing using the Pain Catastrophizing Scale which has 13 items with the anchor: "When I'm in pain…" Items include: "I feel I can't go on." "I feel I can't stand it anymore." "I keep thinking about how much it hurts." The response scale ranges from 0 Not al all to 4 All the Time.

  39. Pain catastrophizing at 12 weeks post baseline [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring pain catastrophizing using the Pain Catastrophizing Scale which has 13 items with the anchor: "When I'm in pain…" Items include: "I feel I can't go on." "I feel I can't stand it anymore." "I keep thinking about how much it hurts." The response scale ranges from 0 Not al all to 4 All the Time.

  40. Patient adherence at baseline [ Time Frame: Administered at baseline ]
    Measuring patient adherence to medical recommendations using the Medical Outcomes Study (MOS) Measures of Patient Adherence. The instrument has 5 items. The first four items ask questions like "I had a hard time doing what the doctor suggested I do… " or "I was unable to do what was necessary to follow my doctor's treatment plans…." The 5th item asks: "Generally speaking, how often during the past 4 weeks were you able to do what the doctor told you?" The 6-item response scale ranges from None of the time to All of the time.

  41. Patient adherence at 8 weeks post baseline [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring patient adherence to medical recommendations using the Medical Outcomes Study (MOS) Measures of Patient Adherence. The instrument has 5 items. The first four items ask questions like "I had a hard time doing what the doctor suggested I do… " or "I was unable to do what was necessary to follow my doctor's treatment plans…." The 5th item asks: "Generally speaking, how often during the past 4 weeks were you able to do what the doctor told you?" The 6-item response scale ranges from None of the time to All of the time.

  42. Patient adherence at 12 weeks post baseline [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring patient adherence to medical recommendations using the Medical Outcomes Study (MOS) Measures of Patient Adherence. The instrument has 5 items. The first four items ask questions like "I had a hard time doing what the doctor suggested I do… " or "I was unable to do what was necessary to follow my doctor's treatment plans…." The 5th item asks: "Generally speaking, how often during the past 4 weeks were you able to do what the doctor told you?" The 6-item response scale ranges from None of the time to All of the time.

  43. Sleep disturbance at baseline using the PROMIS measure [ Time Frame: Administered at baseline ]
    Measuring sleep disturbance using the 4-item PROMIS Short Form v.1.0 - Sleep Disturbance 4a with the anchor: "In the past 7 days…" Three of the items are: "My sleep was refreshing" "I had a problem with my sleep" and "I had difficulty falling asleep." The 5-item response scale ranges from "Not at all" to "Very much." The fourth question is: "My sleep quality was…" with the 5-item response scale ranging from "Very poor" to "Very good."

  44. Sleep disturbance at 8 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 8 weeks post baseline ]
    Measuring sleep disturbance using the 4-item PROMIS Short Form v.1.0 - Sleep Disturbance 4a with the anchor: "In the past 7 days…" Three of the items are: "My sleep was refreshing" "I had a problem with my sleep" and "I had difficulty falling asleep." The 5-item response scale ranges from "Not at all" to "Very much." The fourth question is: "My sleep quality was…" with the 5-item response scale ranging from "Very poor" to "Very good."

  45. Sleep disturbance at 12 weeks post baseline using the PROMIS measure [ Time Frame: Administered at 12 weeks post baseline ]
    Measuring sleep disturbance using the 4-item PROMIS Short Form v.1.0 - Sleep Disturbance 4a with the anchor: "In the past 7 days…" Three of the items are: "My sleep was refreshing" "I had a problem with my sleep" and "I had difficulty falling asleep." The 5-item response scale ranges from "Not at all" to "Very much." The fourth question is: "My sleep quality was…" with the 5-item response scale ranging from "Very poor" to "Very good."


Other Outcome Measures:
  1. Use of prescription medication in the patient's Electronic Health Record at 12 weeks post baseline [ Time Frame: EHR data pull at 12 weeks post baseline ]
    We will look at the patient's medical record from the EHR datapull to cross-reference the self-reported prescription medication use

  2. Use of non-prescription medication in the patient's Electronic Health Record at 12 weeks post baseline [ Time Frame: EHR data pull at 12 weeks post baseline ]
    We will look at the patient's medical record from the EHR datapull to cross-reference the self-reported non-prescription medication use

  3. Results of physical examinations in the patient's Electronic Health Record at 12 weeks post baseline [ Time Frame: EHR data pull at 12 weeks post baseline ]
    We will look at the patient's medical record from the EHR datapull to cross-reference the self-reported pain on average over 7 days at baseline, 8 weeks post baseline, and at 12 weeks post baseline



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 18 and over
  • Current patient at Northwestern Memorial Hospital
  • Seeking treatment for chronic musculoskeletal pain at the Northwestern Osher Center for Integrative Medicine. Pain will be defined as persisting for at least the past three months with an average level over the past month of at least 4 of 10 on a numerical rating scale, including back pain, neck pain/cervicalgia, knee pain, other joint pain (hips, ankles), fibromyalgia, osteoarthritis and rheumatoid arthritis.
  • Fluent in the English language
  • Have a working email address
  • Have reliable Internet access in order to access the website online

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03699553


Contacts
Layout table for location contacts
Contact: Elizabeth Addington, PhD 312-503-3808 elizabeth.addington@northwestern.edu
Contact: Eva Shiu, MPH 312-503-5195 eva.shiu@northwestern.edu

Locations
Layout table for location information
United States, Illinois
Osher Center for Integrative Medicine Recruiting
Chicago, Illinois, United States, 60611
Contact: Veronika Grote       veronika-grote@northwestern.edu   
Sponsors and Collaborators
Northwestern University
BraveNet
Layout table for additonal information
Responsible Party: Judith Moskowitz, Professor, Northwestern University
ClinicalTrials.gov Identifier: NCT03699553    
Other Study ID Numbers: SP0042991
First Posted: October 9, 2018    Key Record Dates
Last Update Posted: September 10, 2020
Last Verified: September 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Judith Moskowitz, Northwestern University:
online intervention
chronic pain
positive emotion
affective science
Additional relevant MeSH terms:
Layout table for MeSH terms
Musculoskeletal Pain
Chronic Pain
Pain
Neurologic Manifestations
Muscular Diseases
Musculoskeletal Diseases